197 related articles for article (PubMed ID: 26047604)
1. The relationship between telomere length and clinicopathologic characteristics in colorectal cancers among Tunisian patients.
Mzahma R; Kharrat M; Fetiriche F; Bouasker ; Ben Moussa M; Ben Safta Z; Dziri C; Zaouche A; Chaabouni-Bouhamed H
Tumour Biol; 2015 Nov; 36(11):8703-13. PubMed ID: 26047604
[TBL] [Abstract][Full Text] [Related]
2. Relative telomere lengths in tumor and normal mucosa are related to disease progression and chromosome instability profiles in colorectal cancer.
Suraweera N; Mouradov D; Li S; Jorissen RN; Hampson D; Ghosh A; Sengupta N; Thaha M; Ahmed S; Kirwan M; Aleva F; Propper D; Feakins RM; Vulliamy T; Elwood NJ; Tian P; Ward RL; Hawkins NJ; Xu ZZ; Molloy PL; Jones IT; Croxford M; Gibbs P; Silver A; Sieber OM
Oncotarget; 2016 Jun; 7(24):36474-36488. PubMed ID: 27167335
[TBL] [Abstract][Full Text] [Related]
3. Telomere length in peripheral leukocytes is associated with immune cell tumor infiltration and prognosis in colorectal cancer patients.
Svenson U; Öberg Å; Stenling R; Palmqvist R; Roos G
Tumour Biol; 2016 Aug; 37(8):10877-82. PubMed ID: 26883253
[TBL] [Abstract][Full Text] [Related]
4. Correlations of telomere length, telomerase activity, and telomeric-repeat binding factor 1 expression in colorectal carcinoma.
Garcia-Aranda C; de Juan C; Diaz-Lopez A; Sanchez-Pernaute A; Torres AJ; Diaz-Rubio E; Balibrea JL; Benito M; Iniesta P
Cancer; 2006 Feb; 106(3):541-51. PubMed ID: 16388518
[TBL] [Abstract][Full Text] [Related]
5. Telomere length in peripheral blood leukocytes is associated with risk of colorectal cancer in Chinese population.
Qin Q; Sun J; Yin J; Liu L; Chen J; Zhang Y; Li T; Shi Y; Wei S; Nie S
PLoS One; 2014; 9(2):e88135. PubMed ID: 24498432
[TBL] [Abstract][Full Text] [Related]
6. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer.
Engelhardt M; Drullinsky P; Guillem J; Moore MA
Clin Cancer Res; 1997 Nov; 3(11):1931-41. PubMed ID: 9815582
[TBL] [Abstract][Full Text] [Related]
7. Telomere length and human telomerase reverse transcriptase expression as markers for progression and prognosis of colorectal carcinoma.
Gertler R; Rosenberg R; Stricker D; Friederichs J; Hoos A; Werner M; Ulm K; Holzmann B; Nekarda H; Siewert JR
J Clin Oncol; 2004 May; 22(10):1807-14. PubMed ID: 15143073
[TBL] [Abstract][Full Text] [Related]
8. Telomere shortening and the clinicopathologic characteristics of human colorectal carcinomas.
Takagi S; Kinouchi Y; Hiwatashi N; Chida M; Nagashima F; Takahashi S; Negoro K; Shimosegawa T; Toyota T
Cancer; 1999 Oct; 86(8):1431-6. PubMed ID: 10526269
[TBL] [Abstract][Full Text] [Related]
9. Short leukocyte telomere length predicts poor prognosis and indicates altered immune functions in colorectal cancer patients.
Chen Y; Qu F; He X; Bao G; Liu X; Wan S; Xing J
Ann Oncol; 2014 Apr; 25(4):869-876. PubMed ID: 24608194
[TBL] [Abstract][Full Text] [Related]
10. Reduced telomere length in colorectal carcinomas.
Feng TB; Cai LM; Qian KQ; Qi CJ
Asian Pac J Cancer Prev; 2012; 13(2):443-6. PubMed ID: 22524803
[TBL] [Abstract][Full Text] [Related]
11. Relationship between telomere shortening, genetic instability, and site of tumour origin in colorectal cancers.
Rampazzo E; Bertorelle R; Serra L; Terrin L; Candiotto C; Pucciarelli S; Del Bianco P; Nitti D; De Rossi A
Br J Cancer; 2010 Apr; 102(8):1300-5. PubMed ID: 20386541
[TBL] [Abstract][Full Text] [Related]
12. Bleomycin-induced chromosomal damage and shortening of telomeres in peripheral blood lymphocytes of incident cancer patients.
Kroupa M; Polivkova Z; Rachakonda S; Schneiderova M; Vodenkova S; Buchler T; Jiraskova K; Urbanova M; Vodickova L; Hemminki K; Kumar R; Vodicka P
Genes Chromosomes Cancer; 2018 Feb; 57(2):61-69. PubMed ID: 29052312
[TBL] [Abstract][Full Text] [Related]
13. TERT promoter mutations and long telomere length predict poor survival and radiotherapy resistance in gliomas.
Gao K; Li G; Qu Y; Wang M; Cui B; Ji M; Shi B; Hou P
Oncotarget; 2016 Feb; 7(8):8712-25. PubMed ID: 26556853
[TBL] [Abstract][Full Text] [Related]
14. In colon cancer, normal colon tissue and blood cells have altered telomere lengths.
Valls-Bautista C; Piñol-Felis C; Reñé-Espinet JM; Buenestado-García J; Viñas-Salas J
J Surg Oncol; 2015 Jun; 111(7):899-904. PubMed ID: 25873347
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of senescence and cell death factors in non-small cell lung and colorectal tumors showing telomere attrition.
Fernández-Marcelo T; Morán A; de Juan C; Pascua I; Head J; Gómez A; Hernando F; López-Asenjo JA; Hernández S; Sánchez-Pernaute A; Torres AJ; Benito M; Iniesta P
Oncology; 2012; 82(3):153-64. PubMed ID: 22433385
[TBL] [Abstract][Full Text] [Related]
16. Telomeres: Implications for Cancer Development.
Bernal A; Tusell L
Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29351238
[TBL] [Abstract][Full Text] [Related]
17. Leucocytes telomere length and breast cancer risk/ susceptibility: A case-control study.
Pavanello S; Varesco L; Gismondi V; Bruzzi P; Bolognesi C
PLoS One; 2018; 13(5):e0197522. PubMed ID: 29782524
[TBL] [Abstract][Full Text] [Related]
18. Telomere shortening: a biological marker of sporadic colorectal cancer with normal expression of p53 and mismatch repair proteins.
Haghighi MM; Aghagolzadeh P; Zadeh SM; Molaei M; Zali MR; Radpour R
Genet Test Mol Biomarkers; 2014 Apr; 18(4):236-44. PubMed ID: 24495131
[TBL] [Abstract][Full Text] [Related]
19. Telomere attrition and decreased fetuin-A levels indicate accelerated biological aging and are implicated in the pathogenesis of colorectal cancer.
Maxwell F; McGlynn LM; Muir HC; Talwar D; Benzeval M; Robertson T; Roxburgh CS; McMillan DC; Horgan PG; Shiels PG
Clin Cancer Res; 2011 Sep; 17(17):5573-81. PubMed ID: 21753158
[TBL] [Abstract][Full Text] [Related]
20. Telomere length varies by DNA extraction method: implications for epidemiologic research.
Cunningham JM; Johnson RA; Litzelman K; Skinner HG; Seo S; Engelman CD; Vanderboom RJ; Kimmel GW; Gangnon RE; Riegert-Johnson DL; Baron JA; Potter JD; Haile R; Buchanan DD; Jenkins MA; Rider DN; Thibodeau SN; Petersen GM; Boardman LA
Cancer Epidemiol Biomarkers Prev; 2013 Nov; 22(11):2047-54. PubMed ID: 24019396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
